SPC25 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.96429547574917E-14 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.75071068753141E-12 |
Normal-vs-Stage2 |
4.18639999999471E-07 |
Normal-vs-Stage3 |
8.40794101009124E-12 |
Normal-vs-Stage4 |
9.1163000481842E-09 |
Stage1-vs-Stage2 |
6.615400E-01 |
Stage1-vs-Stage3 |
4.335800E-02 |
Stage1-vs-Stage4 |
1.177210E-03 |
Stage2-vs-Stage3 |
3.470400E-01 |
Stage2-vs-Stage4 |
5.956800E-03 |
Stage3-vs-Stage4 |
1.995930E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.64401825486493E-12 |
Normal-vs-AfricanAmerican |
4.88320000002762E-06 |
Normal-vs-Asian |
4.647800E-02 |
Caucasian-vs-AfricanAmerican |
1.200960E-01 |
Caucasian-vs-Asian |
5.135400E-01 |
AfricanAmerican-vs-Asian |
1.949820E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
6.60582699651968E-14 |
Normal-vs-Female |
9.14923692363345E-12 |
Male-vs-Female |
2.508800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
5.87199999999566E-05 |
Normal-vs-Age(41-60Yrs) |
9.35251875944232E-13 |
Normal-vs-Age(61-80Yrs) |
4.81215067793528E-12 |
Normal-vs-Age(81-100Yrs) |
2.969900E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.335600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.427800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.076780E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.202800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.461400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.558200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.700300E-03 |
Normal-vs-Grade 2 |
1.00419672577345E-12 |
Normal-vs-Grade 3 |
3.34032801418971E-12 |
Normal-vs-Grade 4 |
3.33040000022322E-07 |
Grade 1-vs-Grade 2 |
6.128400E-01 |
Grade 1-vs-Grade 3 |
1.262250E-01 |
Grade 1-vs-Grade 4 |
6.820600E-03 |
Grade 2-vs-Grade 3 |
8.171600E-02 |
Grade 2-vs-Grade 4 |
8.415000E-03 |
Grade 3-vs-Grade 4 |
3.569700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.14894768646445E-12 |
Normal-vs-ccB subtype |
4.80789963397399E-10 |
ccA subtype-vs-ccB subtype |
8.286300E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.05979677758705E-12 |
Normal-vs-N1 |
1.38390000004041E-06 |
N0-vs-N1 |
1.66334999999185E-05 |
|
|